Skip to content
PubMed This is a summary of 98 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 98 referenced papers

Top Authors

Carien L. Creutzberg
Leiden University Medical Center
Remi A. Nout
Erasmus MC
Bhavana Pothuri
NYU Langone Health
Tjalling Bosse
Leiden University Medical Center
Andrea Mariani
Mayo Clinic
Vincent T.H.B.M. Smit
Leiden University Medical Center
Matthew A. Powell
Washington University in St. Louis
Hans W. Nijman
University Medical Center Groningen
Ina Maria Jurgenliemk-Schulz
University Medical Center Utrecht

Top Institutions

Ranked by publications Top 10 institutions
09

Medisch Spectrum Twente

Enschede, The Netherlands

21 papers
10

References

References (98)
  1. 1

    Patterns and utility of routine surveillance in high grade endometrial cancer.

    Hunn J, Tenney ME, Tergas AI, et al.

    Gynecologic oncology 2015; (137(3)):485-9.

    PMID: 25838164
  2. 2

    Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

    Bosse T, Peters EE, Creutzberg CL, et al.

    European journal of cancer (Oxford, England : 1990) 2015; (51(13)):1742-50.

    PMID: 26049688
  3. 3

    Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

    Meyer LA, Bohlke K, Powell MA, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015; (33(26)):2908-13 doi:10.1200/JCO.2015.62.5459.

    PMID: 26150442
  4. 4

    The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.

    Cote ML, Ruterbusch JJ, Olson SH, et al.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015; (24(9)):1407-15 doi:10.1158/1055-9965.EPI-15-0316.

    PMID: 26290568
  5. 5

    Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.

    de Boer SM, Nout RA, Jürgenliemk-Schulz IM, et al.

    International journal of radiation oncology, biology, physics 2015; (93(4)):797-809.

    PMID: 26530748
  6. 6

    The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis.

    van Hanegem N, Prins MM, Bongers MY, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (197()):147-55.

    PMID: 26748390
  7. 7

    Genetic counseling and cascade genetic testing in Lynch syndrome.

    Hampel H

    Familial cancer 2016; (15(3)):423-7 doi:10.1007/s10689-016-9893-5.

    PMID: 26969309
  8. 8

    Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.

    Stelloo E, Nout RA, Osse EM, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2016; (22(16)):4215-24 doi:10.1158/1078-0432.CCR-15-2878.

    PMID: 27006490
  9. 9

    Management of Iron Deficiency Anemia.

    Jimenez K, Kulnigg-Dabsch S, Gasche C

    Gastroenterology & hepatology 2015; (11(4)):241-50.

    PMID: 27099596
  10. 10

    Management of Deep Vein Thrombosis (DVT) Prophylaxis in Trauma Patients.

    Paydar S, Sabetian G, Khalili H, et al.

    Bulletin of emergency and trauma 2016; (4(1)):1-7.

    PMID: 27162921
  11. 11

    Diagnostic workup for postmenopausal bleeding: a randomised controlled trial.

    van Hanegem N, Breijer MC, Slockers SA, et al.

    BJOG : an international journal of obstetrics and gynaecology 2017; (124(2)):231-240 doi:10.1111/1471-0528.14126.

    PMID: 27225535
  12. 12

    Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer.

    Foerster R, Schnetzke L, Bruckner T, et al.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2016; (192(12)):895-904 doi:10.1007/s00066-016-1037-1.

    PMID: 27605238
  13. 13

    Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.

    Bendifallah S, Ouldamer L, Lavoue V, et al.

    Gynecologic oncology 2017; (144(1)):107-112 doi:10.1016/j.ygyno.2016.10.025.

    PMID: 27789083
  14. 14

    Fertility-preservation in endometrial cancer: is it safe? Review of the literature.

    Carneiro MM, Lamaita RM, Ferreira MC, Silva-Filho AL

    JBRA assisted reproduction 2016; (20(4)):232-239 doi:10.5935/1518-0557.20160045.

    PMID: 28050959
  15. 15

    Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.

    Jeppesen MM, Mogensen O, Hansen DG, et al.

    Acta oncologica (Stockholm, Sweden) 2017; (56(2)):262-269 doi:10.1080/0284186X.2016.1267396.

    PMID: 28080157
  16. 16

    Sexual Function and Quality of Life Among Patients With Endometrial Cancer After Surgery.

    Gao H, Xiao M, Bai H, Zhang Z

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017; (27(3)):608-612 doi:10.1097/IGC.0000000000000905.

    PMID: 28129240
  17. 17

    A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.

    Rossi EC, Kowalski LD, Scalici J, et al.

    The Lancet. Oncology 2017; (18(3)):384-392 doi:10.1016/S1470-2045(17)30068-2.

    PMID: 28159465
  18. 18

    Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.

    Dillon JL, Gonzalez JL, DeMars L, et al.

    Human pathology 2017; (70()):121-128 doi:10.1016/j.humpath.2017.10.022.

    PMID: 29107668
  19. 19

    Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.

    Geppert B, Lönnerfors C, Bollino M, Persson J

    Gynecologic oncology 2018; (148(3)):491-498 doi:10.1016/j.ygyno.2017.12.017.

    PMID: 29273307
  20. 20

    Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis.

    Sasaki LMP, Andrade KRC, Figueiredo ACMG, et al.

    Journal of minimally invasive gynecology 2018; (25(5)):777-785 doi:10.1016/j.jmig.2018.02.004.

    PMID: 29454147
  21. 21

    ACOG Committee Opinion No. 734 Summary: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.

    Obstetrics and gynecology 2018; (131(5)):945-946 doi:10.1097/AOG.0000000000002626.

    PMID: 29683904
  22. 22

    ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.

    Obstetrics and gynecology 2018; (131(5)):e124-e129 doi:10.1097/AOG.0000000000002631.

    PMID: 29683909
  23. 23

    Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer.

    Doll KM, Khor S, Odem-Davis K, et al.

    American journal of obstetrics and gynecology 2018; (219(6)):593.e1-593.e14 doi:10.1016/j.ajog.2018.09.040.

    PMID: 30291839
  24. 24

    Molecular Genetics of Endometrial Carcinoma.

    Bell DW, Ellenson LH

    Annual review of pathology 2019; (14()):339-367 doi:10.1146/annurev-pathol-020117-043609.

    PMID: 30332563
  25. 25

    Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.

    Wortman BG, Creutzberg CL, Putter H, et al.

    British journal of cancer 2018; (119(9)):1067-1074 doi:10.1038/s41416-018-0310-8.

    PMID: 30356126
  26. 26

    Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results.

    Delishaj D, Barcellini A, D'Amico R, et al.

    Journal of contemporary brachytherapy 2018; (10(6)):559-566 doi:10.5114/jcb.2018.79713.

    PMID: 30662479
  27. 27

    Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies.

    Jennings JJ, Mandaliya R, Nakshabandi A, Lewis JH

    Expert opinion on drug metabolism & toxicology 2019; (15(3)):231-244 doi:10.1080/17425255.2019.1574744.

    PMID: 30677306
  28. 28

    Sentinel node navigation surgery in cervical and endometrial cancer: a review.

    Niikura H, Tsuji K, Tokunaga H, et al.

    Japanese journal of clinical oncology 2019; (49(6)):495-500 doi:10.1093/jjco/hyz062.

    PMID: 31070770
  29. 29

    Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.

    Clarke MA, Devesa SS, Harvey SV, Wentzensen N

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019; (37(22)):1895-1908 doi:10.1200/JCO.19.00151.

    PMID: 31116674
  30. 30

    The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis.

    Saed L, Varse F, Baradaran HR, et al.

    BMC cancer 2019; (19(1)):527 doi:10.1186/s12885-019-5748-4.

    PMID: 31151429
  31. 31

    p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.

    Parra-Herran C, Bassiouny D, Lerner-Ellis J, et al.

    The American journal of surgical pathology 2019; (43(12)):1591-1599 doi:10.1097/PAS.0000000000001328.

    PMID: 31335355
  32. 32

    Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding.

    Ilavarasi CR, Jyothi GS, Alva NK

    Journal of mid-life health 2019; (10(2)):75-80 doi:10.4103/jmh.JMH_109_18.

    PMID: 31391756
  33. 33

    Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.

    Fukihara J, Sakamoto K, Koyama J, et al.

    Clinical lung cancer 2019; (20(6)):442-450.e4 doi:10.1016/j.cllc.2019.07.006.

    PMID: 31446020
  34. 34

    Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management.

    Shivaji UN, Jeffery L, Gui X, et al.

    Therapeutic advances in gastroenterology 2019; (12()):1756284819884196 doi:10.1177/1756284819884196.

    PMID: 31723355
  35. 35

    Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.

    Casarin J, Multinu F, Tortorella L, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(1)):41-47 doi:10.1136/ijgc-2019-000672.

    PMID: 31780567
  36. 36

    Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer.

    Beaver K, Martin-Hirsch P, Williamson S, Kyrgiou M

    European journal of oncology nursing : the official journal of European Oncology Nursing Society 2020; (44()):101704 doi:10.1016/j.ejon.2019.101704.

    PMID: 31812918
  37. 37

    Adjuvant chemotherapy in endometrial cancer.

    Gómez-Raposo C, Merino Salvador M, Aguayo Zamora C, Casado Saenz E

    Cancer chemotherapy and pharmacology 2020; (85(3)):477-486 doi:10.1007/s00280-019-04027-6.

    PMID: 31950214
  38. 38

    Impact of quality of care on racial disparities in survival for endometrial cancer.

    Huang AB, Huang Y, Hur C, et al.

    American journal of obstetrics and gynecology 2020; (223(3)):396.e1-396.e13 doi:10.1016/j.ajog.2020.02.021.

    PMID: 32109459
  39. 39

    External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.

    Narasimhulu DM, Cope A, Riaz IB, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(6)):797-805 doi:10.1136/ijgc-2020-001199.

    PMID: 32221021
  40. 40

    FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis.

    Arora S, Balasubramaniam S, Zhang W, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2020; (26(19)):5062-5067 doi:10.1158/1078-0432.CCR-19-3979.

    PMID: 32295834
  41. 41

    Clinicopathologic Characteristics and Causes of Postmenopausal Bleeding in Older Patients.

    Jo HC, Baek JC, Park JE, et al.

    Annals of geriatric medicine and research 2018; (22(4)):189-193 doi:10.4235/agmr.18.0042.

    PMID: 32743272
  42. 42

    Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.

    León-Castillo A, de Boer SM, Powell ME, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(29)):3388-3397 doi:10.1200/JCO.20.00549.

    PMID: 32749941
  43. 43

    Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study.

    Wedin M, Stålberg K, Marcickiewicz J, et al.

    Gynecologic oncology 2020; (159(1)):201-208 doi:10.1016/j.ygyno.2020.07.014.

    PMID: 32763108
  44. 44

    The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.

    Ryan NAJ, McMahon R, Tobi S, et al.

    PLoS medicine 2020; (17(9)):e1003263 doi:10.1371/journal.pmed.1003263.

    PMID: 32941469
  45. 45

    ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.

    , Reinhold C, Ueno Y, et al.

    Journal of the American College of Radiology : JACR 2020; (17(11S)):S472-S486 doi:10.1016/j.jacr.2020.09.001.

    PMID: 33153558
  46. 46

    Fertility-sparing treatment in women with endometrial cancer.

    Won S, Kim MK, Seong SJ

    Clinical and experimental reproductive medicine 2020; (47(4)):237-244 doi:10.5653/cerm.2020.03629.

    PMID: 33181010
  47. 47

    Signs and symptoms associated with uterine cancer in pre- and postmenopausal women.

    Boeckstaens S, Dewalheyns S, Heremans R, et al.

    Heliyon 2020; (6(11)):e05372 doi:10.1016/j.heliyon.2020.e05372.

    PMID: 33204876
  48. 48

    Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer.

    Glaser G, Dinoi G, Multinu F, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021; (31(1)):85-91 doi:10.1136/ijgc-2020-001924.

    PMID: 33243776
  49. 49

    The struggle against endometrial cancer: ten years of experience of a tertiary center.

    Bilgi A, Guler AH, Kulhan M, et al.

    Ginekologia polska 2022; (93(5)):351-360 doi:10.5603/GP.a2021.0138.

    PMID: 34155618
  50. 50

    Obesity increases endometrial cancer risk in Chinese women with postmenopausal bleeding.

    Liu F, Cheung ECW, Lao TT

    Menopause (New York, N.Y.) 2021; (28(10)):1093-1098 doi:10.1097/GME.0000000000001822.

    PMID: 34183566
  51. 51

    Consecutive severe immune-related adverse events after PD-1 inhibitor induction and surgery in locally advanced non-small cell lung cancer: a case report.

    Zhao H, Ning J, Gu Y, et al.

    Translational lung cancer research 2021; (10(8)):3682-3688 doi:10.21037/tlcr-21-603.

    PMID: 34584866
  52. 52

    Association of Myometrial Invasion With Lymphovascular Space Invasion, Lymph Node Metastasis, Recurrence, and Overall Survival in Endometrial Cancer: A Meta-Analysis of 79 Studies With 68,870 Patients.

    Wang J, Xu P, Yang X, et al.

    Frontiers in oncology 2021; (11()):762329 doi:10.3389/fonc.2021.762329.

    PMID: 34746002
  53. 53

    Clinical issues of surgery for uterine endometrial cancer in Japan.

    Nagai T, Shimada M, Tokunaga H, et al.

    Japanese journal of clinical oncology 2022; (52(4)):346-352 doi:10.1093/jjco/hyab211.

    PMID: 35032166
  54. 54

    Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.

    Makker V, Colombo N, Casado Herráez A, et al.

    The New England journal of medicine 2022; (386(5)):437-448 doi:10.1056/NEJMoa2108330.

    PMID: 35045221
  55. 55

    Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients.

    Zou J, Huang P, Ge N, et al.

    Journal of gastrointestinal oncology 2022; (13(4)):1898-1906 doi:10.21037/jgo-22-643.

    PMID: 36092355
  56. 56

    Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.

    Uccella S, Zorzato PC, Dababou S, et al.

    Medicina (Kaunas, Lithuania) 2022; (58(9)) doi:10.3390/medicina58091256.

    PMID: 36143933
  57. 57

    Uterine disorders and iron deficiency anemia.

    Donnez J, Carmona F, Maitrot-Mantelet L, et al.

    Fertility and sterility 2022; (118(4)):615-624 doi:10.1016/j.fertnstert.2022.08.011.

    PMID: 36182260
  58. 58

    Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline.

    Harkenrider MM, Abu-Rustum N, Albuquerque K, et al.

    Practical radiation oncology 2023; (13(1)):41-65 doi:10.1016/j.prro.2022.09.002.

    PMID: 36280107
  59. 59

    Endometrial Hyperplasia.

    Ring KL, Mills AM, Modesitt SC

    Obstetrics and gynecology 2022; (140(6)):1061-1075 doi:10.1097/AOG.0000000000004989.

    PMID: 36357974
  60. 60

    Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.

    Kurokawa K, Mitsuishi Y, Shimada N, et al.

    Thoracic cancer 2023; (14(5)):442-449 doi:10.1111/1759-7714.14761.

    PMID: 36523162
  61. 61

    Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(1)):109-117 doi:10.1136/ijgc-2022-004039.

    PMID: 36600534
  62. 62

    A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.

    Makker V, Aghajanian C, Cohn AL, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023; (41(5)):974-979 doi:10.1200/JCO.22.01021.

    PMID: 36608305
  63. 63

    Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.

    Meixner E, Wark A, Forster T, et al.

    Radiation oncology (London, England) 2023; (18(1)):5 doi:10.1186/s13014-023-02198-4.

    PMID: 36624483
  64. 64

    "The Great Masquerader": An Interesting Case Series of Pulmonary Thromboembolism.

    Sritharan SB, Raj CP, Ta V, et al.

    Cureus 2022; (14(12)):e32330 doi:10.7759/cureus.32330.

    PMID: 36632266
  65. 65

    Biomarker-driven therapy in endometrial cancer.

    Karpel H, Slomovitz B, Coleman RL, Pothuri B

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(3)):343-350 doi:10.1136/ijgc-2022-003676.

    PMID: 36878569
  66. 66

    Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

    Eskander RN, Sill MW, Beffa L, et al.

    The New England journal of medicine 2023; (388(23)):2159-2170 doi:10.1056/NEJMoa2302312.

    PMID: 36972022
  67. 67

    Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

    Mirza MR, Chase DM, Slomovitz BM, et al.

    The New England journal of medicine 2023; (388(23)):2145-2158 doi:10.1056/NEJMoa2216334.

    PMID: 36972026
  68. 68

    Endometrial biopsy: Indications, techniques and recommendations. An evidence-based guideline for clinical practice.

    Vitale SG, Buzzaccarini G, Riemma G, et al.

    Journal of gynecology obstetrics and human reproduction 2023; (52(6)):102588 doi:10.1016/j.jogoh.2023.102588.

    PMID: 37061093
  69. 69

    Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group.

    Oliver-Perez MR, Padilla-Iserte P, Arencibia-Sanchez O, et al.

    Cancers 2023; (15(9)) doi:10.3390/cancers15092612.

    PMID: 37174081
  70. 70

    An atypical presentation of endometrial cancer as angina secondary to critically low hemoglobin and iron deficiency associated pancytopenia: A case report.

    Crawford G, Bahabri A, P'ng S

    Case reports in women's health 2023; (38()):e00509 doi:10.1016/j.crwh.2023.e00509.

    PMID: 37180555
  71. 71

    Conservative treatment of endometrial cancer in women of reproductive age (Review).

    Bourou MZ, Matsas A, Vrekoussis T, et al.

    Molecular and clinical oncology 2023; (19(1)):55 doi:10.3892/mco.2023.2651.

    PMID: 37323245
  72. 72

    FIGO staging of endometrial cancer: 2023.

    Berek JS, Matias-Guiu X, Creutzberg C, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2023; (162(2)):383-394 doi:10.1002/ijgo.14923.

    PMID: 37337978
  73. 73

    The role of TCGA molecular classification in clear cell endometrial carcinoma.

    Tang X, Hu Y

    Frontiers in oncology 2023; (13()):1147394 doi:10.3389/fonc.2023.1147394.

    PMID: 37456263
  74. 74

    FIGO staging of endometrial cancer: 2023.

    Berek JS, Matias-Guiu X, Creutzberg C, et al.

    Journal of gynecologic oncology 2023; (34(5)):e85 doi:10.3802/jgo.2023.34.e85.

    PMID: 37593813
  75. 75

    Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy.

    Yao M, Ma J, Wu D, et al.

    Frontiers in immunology 2023; (14()):1198952 doi:10.3389/fimmu.2023.1198952.

    PMID: 37680629
  76. 76

    PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.

    Loukovaara M, Bützow R, Staff S, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(11)):1807-1811 doi:10.1136/ijgc-2023-004939.

    PMID: 37813479
  77. 77

    Comparing endometrial biopsy results with hysteroscopic pathology in women presenting with abnormal and postmenopausal uterine bleeding.

    Ferrando CA, Lintel MK, Bradley LD

    Journal of gynecology obstetrics and human reproduction 2023; (52(10)):102685 doi:10.1016/j.jogoh.2023.102685.

    PMID: 37871649
  78. 78

    Sentinel lymph node mapping in endometrial cancer: Current evidence and practice.

    Salman L, Cusimano MC, Marchocki Z, Ferguson SE

    Journal of surgical oncology 2024; (129(1)):117-119 doi:10.1002/jso.27550.

    PMID: 38059317
  79. 79

    Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on the Use of Primary Chemoimmunotherapy to Treat Patients with Locally Advanced or Recurrent Endometrial Cancer.

    Tempfer C, Brucker S, Juhasz-Boess I, et al.

    Geburtshilfe und Frauenheilkunde 2023; (83(9)):1095-1101 doi:10.1055/a-2145-1545.

    PMID: 38230409
  80. 80

    How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer.

    Dinoi G, Garzon S, Weaver A, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024; (34(9)):1389-1398.

    PMID: 38821549
  81. 81

    Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.

    Powell MA, Bjørge L, Willmott L, et al.

    Annals of oncology : official journal of the European Society for Medical Oncology 2024; (35(8)):728-738 doi:10.1016/j.annonc.2024.05.546.

    PMID: 38866180
  82. 82

    A prospective study of endometrial histopathology in post-menopausal women in Jharkhand.

    Kumari K, Paswan MK, Kundan M, Ambedkar SN

    Journal of family medicine and primary care 2024; (13(5)):1696-1700 doi:10.4103/jfmpc.jfmpc_1331_23.

    PMID: 38948580
  83. 83

    New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.

    Yasuda M

    Pathology international 2024; (74(10)):557-573 doi:10.1111/pin.13471.

    PMID: 39175262
  84. 84

    Impact of Vaginal Dilator Use and 68 Gy EQD2(α/β=3) Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer.

    Noorian F, Abellana R, Zhang Y, et al.

    Journal of personalized medicine 2024; (14(8)) doi:10.3390/jpm14080838.

    PMID: 39202029
  85. 85

    Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

    Auranen A, Powell MA, Sukhin V, et al.

    Therapeutic advances in medical oncology 2024; (16()):17588359241277656 doi:10.1177/17588359241277656.

    PMID: 39346117
  86. 86

    The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025.

    Silk T, Hacker KE, Growdon W, Pothuri B

    Current opinion in obstetrics & gynecology 2025; (37(1)):22-29 doi:10.1097/GCO.0000000000001004.

    PMID: 39611619
  87. 87

    Quality of life and climacteric symptoms in women with endometrial cancer: examining the impact of lower limb lymphedema.

    Li CC, Chang TC, Chang CW, et al.

    Journal of patient-reported outcomes 2025; (9(1)):66 doi:10.1186/s41687-025-00895-0.

    PMID: 40512268
  88. 88

    Epidemiology, molecular typing, microbiome-immune interactions and treatment strategies of endometrial cancer: a review.

    Liang B, Tan J, Li J, et al.

    Frontiers in immunology 2025; (16()):1595638 doi:10.3389/fimmu.2025.1595638.

    PMID: 40636107
  89. 89

    Fertility-sparing treatments for patients with endometrial cancer: A comprehensive review.

    Seol A, Jeong HG, Kim S, Lee S

    Clinical and experimental reproductive medicine 2026; (53(1)):1-9 doi:10.5653/cerm.2023.06814.

    PMID: 41069261
  90. 90

    Performance of ultrasound and rates of guideline-concordant care in a diverse postmenopausal bleeding cohort.

    Nolin AC, Atkins S, Brucker A, et al.

    American journal of obstetrics and gynecology 2026; (234(2)):400-416 doi:10.1016/j.ajog.2025.10.002.

    PMID: 41077302
  91. 91

    Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001).

    Lee AJ, Jang EB, Suh DH, et al.

    Gynecologic oncology 2025; (203()):191-197 doi:10.1016/j.ygyno.2025.10.036.

    PMID: 41237702
  92. 92

    Key considerations for safe de-escalation of therapy for POLE mutated endometrial cancer.

    Martin SD, McAlpine JN

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; 102810 doi:10.1016/j.ijgc.2025.102810.

    PMID: 41775567
  93. 93

    Endometrial Cancer: A Review.

    Mager KL, McLean K

    JAMA 2026; (335(18)):1616-1627 doi:10.1001/jama.2026.2248.

    PMID: 41973450
  94. 94

    Visually Directed Hysteroscopic Biopsy in the Evaluation of Abnormal Uterine Bleeding and Postmenopausal Bleeding: A Joint Society Practice Guideline.

    Journal of minimally invasive gynecology 2026; (33(8)):1027-1040 doi:10.1016/j.jmig.2026.06.018.

    PMID: 42336133
  95. 95

    Validation of the 2023 International Federation of Gynecology and Obstetrics staging system in a large retrospective cohort.

    Demirden A, Keles E, Şanlıkan F, et al.

    Revista da Associacao Medica Brasileira (1992) 2026; (72(3)):e20251624 doi:10.1590/1806-9282.20251624.

    PMID: 42384971
  96. 96

    Clinical utility of diagnosing Lynch syndrome in gynecologic oncology: a joint statement from four Japanese academic societies.

    Sato S, Masuda K, Oda K, et al.

    International journal of clinical oncology 2026; (31(9)):1742-1755 doi:10.1007/s10147-026-03126-8.

    PMID: 42435282
  97. 97

    Personalizing endometrial cancer care beyond histology: clinical applications and limits of molecular classification.

    Marchetti M, Panizzolo E, Caruso G, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; (36(9)):104882 doi:10.1016/j.ijgc.2026.104882.

    PMID: 42617416
  98. 98

    A perspective on the revised American College of Obstetricians and Gynecologists' guidance for transvaginal ultrasound in the evaluation of postmenopausal bleeding.

    Goldstein SR

    Menopause (New York, N.Y.) 2026; doi:10.1097/GME.0000000000002902.

    PMID: 42677969